Changing the treatment
paradigm
Developing miRNA therapeutics for age-related and fibrotic disorders
Our Technology
Healthy Ageing through musculoskeletal health
MicroRNA therapies have almost limitless therapeutic potential
Our Pipeline
Changing the treatment paradigm
As Causeway’s Tendinopathy program moves into clinical development, we continue to expand our pre-clinical programs focusing on age-related indications that have the potential re-define what it means to grow old.
Programs
As Causeway’s Tendinopathy program moves into clinical development, we continue to expand our pre-clinical programs focusing on age-related indications that have the potential re-define what it means to grow old.
CardioMiR for Heart disease
DermaMiR™
for skin-ageing
TenoMiR
for Tendinopathy
About Us
Our goal is to develop therapies that treat the most common musculoskeletal diseases, such as osteoarthritis and tendinopathy, re-defining what old age looks and feels like.